- Why are vegetarians more likely to suffer from depression than meat eaters?
- Small wireless device implanted between skin and skull helps kill cancer cells
- Will the mRNA vaccine that can cure cancer come out near soon?
- Allogeneic T-cell therapy set for landmark first approval
- Boston University denies that the new COVID strain they made has 80% fatality rate
- A new generation of virus-free CAR-T cell therapy
All cancers can be simply divided into two categories, according to whether they express YAP protein
- First human trial of HIV gene therapy: A one-time cure will be achieved if successful!
- New breakthrough in CAR-T cell therapy: Lupus erythematosus patients achieved treatment-free remission for up to 17 months
- How long can the patient live after heart stent surgery?
- First time: Systemic multi-organ recovery after death
- Where do the bacteria in the human gut come from?
Cancer Cell: All cancers can be simply divided into two categories, according to whether they express YAP protein.
YAP protein (Yes-Associated Protein)is the core effector of the Hippo signaling pathway.
It is a multifunctional intracellular connexin and transcription co-activator, which plays a role in signal transduction and gene transcription regulation in normal cells.
Many studies have shown that YAP is involved in tumorigenesis and development, and plays the role of oncogene in the body. Increased expression and activity of YAP can promote malignant transformation of cells.
In July 2021, researchers from Toronto Mount Sinai Hospital and the University of Toronto published a research paper titled Binary pan-cancer classes with distinct vulnerabilities defined by pro- or anti-cancer YAP/TEAD activity in Cancer Cell .
The study shows that all cancers can be divided into two categories based on whether they express YAP protein.
This discovery provides a new strategy for the treatment of the most aggressive and incurable types of cancer.
As an important regulator and effector of the Hippo signaling pathway, YAP plays an important role in the formation of malignant tumors.
YAP exists in all cancers, regardless of whether its expression is turned on or off. This is related to its drug sensitivity or drug resistance.
When culturing cancer cells in the laboratory, the cancer cells are either suspended or adherent, and YAP is its main regulator.
All suspended cancer cells are YAP expression turned off ( YAPoff ), and all adherent Cancer cells are all turned on by YAP expression ( YAPon ).
This change in cell adhesion behavior is related to drug resistance and invasiveness, which indicates that YAP is the key to this drug resistance change and malignant transformation.
In cancer cells, the closing or opening of YAP has the opposite effect of promoting or suppressing cancer.
For YAPon cancer, the presence of YAP is required to grow and survive, while for YAPoff cancer, the presence of YAP can inhibit the growth of cancer cells.
The research team also found that YAPoff cancers are usually highly lethal , such as retinoblastoma, small cell lung cancer, and neuroendocrine prostate cancer.
Some cancers such as prostate cancer and lung cancer can also transition from YAPon state to YAPoff state to resist treatment .
Therefore, the method of preventing this YAP state transition can be an effective method of preventing drug resistance.
In general, this study shows that all cancers can be divided into two categories based on the presence or absence of YAP protein- YAPon cancer and YAPoff cancer .
This simple binary classification may have a profound impact on cancer treatment, and can be used to infer the vulnerability of cancer, develop new therapies, and improve the effectiveness of cancer treatment.
Cancer Cell: All cancers can be simply divided into two categories
(source:internet, reference only)